PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Symptom | |hepatitis c |
| Sentences | 114 |
| PubMedID- 24223115 | The progression of hepatic fibrosis is an important predictive factor for the development of lc and hepatocellular carcinoma not only in patients with chronic hepatitis c, but also in those with nash 4. |
| PubMedID- 26070204 | Serum wisteria floribunda agglutinin-positive mac-2 binding protein values predict the development of hepatocellular carcinoma among patients with chronic hepatitis c after sustained virological response. |
| PubMedID- 22066022 | Serum microrna-21 as marker for necroinflammation in hepatitis c patients with and without hepatocellular carcinoma. |
| PubMedID- 21319193 | Liver stiffness measurement (lsm) using fibroscan accurately assesses the degree of liver fibrosis and the risk of hepatocellular carcinoma (hcc) development in patients with chronic hepatitis c. |
| PubMedID- 21610221 | Background: this study explores the influence of two functional genetic polymorphisms in the regulated on activation in normal t-cell expressed and secreted(rantes) promoter on the risk of hepatocellular carcinoma (hcc) occurrence in patients with alcoholic or hepatitis c virus (hcv)-related cirrhosis. |
| PubMedID- 20981260 | A 73-year-old man with a history of hepatocellular carcinoma associated with hepatitis c virus-related cirrhosis was referred to the department of urology because a thickened wall of the urinary bladder was incidentally detected by computed tomography (ct). |
| PubMedID- 24179611 | Chemoprevention of hepatocellular carcinoma in patients with hepatitis c virus related cirrhosis. |
| PubMedID- 23564522 | The effects of interferon (ifn) treatment and the post-ifn treatment alpha-fetoprotein (afp) levels on risk of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c (chc) are unknown. |
| PubMedID- 21526141 | We report a case of hepatocellular carcinoma (hcc) with chronic hepatitis c virus infection successfully treated with percutaneous radiofrequency ablation (rfa) under live four-dimensional (4d) echo guidance. |
| PubMedID- 24463696 | Influence of human t-lymphotropic virus type 1 coinfection on the development of hepatocellular carcinoma in patients with hepatitis c virus infection. |
| PubMedID- 22439008 | stated that phlebotomy therapy may potentially lower the risk of progression to hepatocellular carcinoma (hcc) in patients with hepatitis c virus infection. |
| PubMedID- 25743000 | Objective: to determine the impact of phlebotomy on the laboratory values and the incidence of hepatocellular carcinoma (hcc) in patients with hepatitis c. |
| PubMedID- 24081938 | Statins and reduced risk of hepatocellular carcinoma in patients with hepatitis c virus infection: further evidence is warranted. |
| PubMedID- 25650331 | Purpose: to evaluate whether a hepatic fibrosis index (hfi), quantified on the basis of hepatic contour abnormality, is a risk factor for the development of hepatocellular carcinoma (hcc) in patients with chronic hepatitis c. |